Application of blood plasma miR-208a in early marker for diagnosis of acute myocardial infarction
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
- Publication Date
- 2011-07-27
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
【Technical Field】
[0001] The present invention relates to the technical field of medical molecular biology, and more specifically, to the new use of plasma miR-208a as an early marker for the diagnosis of acute myocardial infarction. 【Background technique】
[0002] MicroRNA (miRNA) is a type of endogenous non-coding small RNAs with only 18-25 nucleotides, which are widely present in various organisms. miRNA binds to the 3'untranslated region (3'-UTR) of target gene mRNA, degrades or inhibits mRNA translation, regulates the expression of target genes, and participates in regulating various biological functions. In 1993, Ambros first discovered a non-coding single-stranded small molecule RNA-lin4 in C. elegans, which has the function of regulating the developmental phase of C. elegans. After nearly 20 years of scientific research, 721 miRNAs (Sanger miRbase 14.0) have been discovered in the human body. These miRNAs play an important regulatory role in many life activities of the h...